SCHEMBL29355651

SCHEMBL29355651

C[S@+]([O-])Cc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1Cl

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 18/20 0.57
▸ CSNK2A1 P68400 4/20 0.57
▸ CSNK2B P67870 2/20 0.57
▸ HIPK2 Q9H2X6 2/20 0.57
▸ KCNH2 Q12809 2/20 0.57
▸ DYRK3 O43781 1/20 0.57
▸ CDK2 P24941 1/20 0.57
▸ GSK3B P49841 1/20 0.57
▸ PIM3 Q86V86 1/20 0.57
▸ HIPK1 Q86Z02 1/20 0.57
▸ DYRK2 Q92630 1/20 0.57
▸ HIPK3 Q9H422 1/20 0.57
▸ STK17A Q9UEE5 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29353278 1.00 CSNK2A2 (0.57) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL30279919 1.00 CSNK2A2 (0.57) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742577 1.00 CSNK2A2 (0.57) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742507 1.00 CSNK2A2 (0.57) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742733 1.00 CSNK2A2 (0.57) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742440 0.92 CSNK2A2 (0.59) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742477 0.90 CSNK2A2 (0.65) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742433 0.90 KCNH2 (0.65) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742422 0.89 CSNK2A2 (0.57) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2
SCHEMBL19742656 0.89 CSNK2A2 (0.60) CSNK2A2CSNK2A1CSNK2BHIPK2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3474855-B1 CK2 INHIBITORS, COMPOSITIONS AND METHODS THEREOF POLARIS PHARMACEUTICALS INC (US) 2022-01-26 — — EP claimed
EP-3474855-B1 CK2 INHIBITORS, COMPOSITIONS AND METHODS THEREOF POLARIS PHARMACEUTICALS INC (US) 2022-01-26 — — EP disclosed
Send feedback